Bridging the gaps in 18F PET tracer development

被引：0

作者：

Michael G. Campbell

Joel Mercier

Christophe Genicot

Véronique Gouverneur

Jacob M. Hooker

Tobias Ritter

机构：

[1] Harvard University,Department of Chemistry and Chemical Biology

[2] Global Chemistry,Division of Nuclear Medicine and Molecular Imaging, Department of Radiology

[3] UCB NewMedicines,undefined

[4] UCB Biopharma SPRL,undefined

[5] Chemistry Research Laboratory,undefined

[6] University of Oxford,undefined

[7] Massachusetts General Hospital,undefined

[8] Athinoula A. Martinos Center for Biomedical Imaging,undefined

[9] Massachusetts General Hospital and Harvard Medical School,undefined

[10] Max-Planck-Institut für Kohlenforschung,undefined

[11] Present Address: Department of Chemistry,undefined

[12] Barnard College,undefined

[13] 3009 Broadway,undefined

[14] New York,undefined

[15] New York 10027,undefined

[16] USA,undefined

来源：

Nature Chemistry | 2017年 / 9卷

关键词：

D O I：

暂无

中图分类号：

学科分类号：

摘要：

As compared to the drug discovery process, the development of new 18F PET tracers lacks a well-established pipeline that advances compounds from academic research to candidacy for (pre)clinical imaging. In order to bridge the gaps between methodological advances and clinical success, we must rethink the development process from training to implementation.

引用

页码：1 / 3

页数：2

共 50 条

[41] State of the art procedures towards reactive [18F]fluoride in PET tracer synthesis
Lizeth Y. F. Haveman
Danielle J. Vugts
Albert D. Windhorst
EJNMMI Radiopharmacy and Chemistry, 8
[42] State of the art procedures towards reactive [18F]fluoride in PET tracer synthesis
Haveman, Lizeth Y. F.
Vugts, Danielle J.
Windhorst, Albert D.
EJNMMI RADIOPHARMACY AND CHEMISTRY, 2023, 8 (01)
[43] Preparation of the hypoxia imaging PET tracer [18F]FAZA:: reaction parameters and automation
Reischl, G
Ehrlichmann, W
Bieg, C
Solbach, C
Kumar, P
Wiebe, LI
Machulla, H
APPLIED RADIATION AND ISOTOPES, 2005, 62 (06) : 897 - 901
[44] 4-[18F]-Tetraphenylphosphonium as a PET Tracer for Myocardial Mitochondrial Membrane Potential
Gurm, Gagandeep S.
Danik, Stephan B.
Shoup, Timothy M.
Weise, Steven
Takahashi, Kazue
Laferrier, Shawna
Elmaleh, David R.
Gewirtz, Henry
JACC-CARDIOVASCULAR IMAGING, 2012, 5 (03) : 285 - 292
[45] Evaluation of [18F]FR - a potential PET tracer for the diagnosis of cerebral amyloid angiopathy
Bleher, Daniel
Poxleitner, Marilena
Bowden, Gregory D.
Buss, Sabrina
Grotegerd, Ann-Kathrin
Schembecker, Sonja
Pichler, Bernd J.
Maurer, Andreas
Herfert, Kristina
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 2021, 41 (1_SUPPL): : 194 - 195
[46] [18F]tetrafluoroborate as a PET tracer for the sodium/iodide symporter: the importance of specific activity
Khoshnevisan, Alex
Jauregui-Osoro, Maite
Shaw, Karen
Torres, Julia Baguna
Young, Jennifer D.
Ramakrishnan, Nisha K.
Jackson, Alex
Smith, Gareth E.
Gee, Antony D.
Blower, Philip J.
EJNMMI RESEARCH, 2016, 6
[47] AN ALTERNATE SYNTHESIS OF [18F]FAZA: A CLINICALLY USED PET TRACER FOR TISSUE HYPOXIA
Kumar, P.
Wiebe, L. I.
McEwan, A. J. B.
JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, 2005, 48 : S203 - S203
[48] Evaluation of [18F]-JNJ-64326067-AAA tau PET tracer in humans
Baker, Suzanne L.
Provost, Karine
Thomas, Wesley
Whitman, A. J.
Janabi, Mustafa
Schmidt, Mark E.
Timmers, Maarten
Kolb, Hartmuth C.
Rabinovici, Gil D.
Jagust, William J.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 2021, 41 (12): : 3302 - 3313
[49] [18F]FPyGaI: A novel β-galactosidase specific PET tracer for in vivoimaging of tumor senescence
Krueger, Marcel A.
Cotton, Jonathan M.
Zhou, Benyuan
Wolter, Katharina
Schwenck, Johannes
Kuehn, Anna
Fuchs, Kerstin
Maurer, Andreas
La Fougere, Christian
Zenderand, Lars
Pichler, Bernd J.
CANCER RESEARCH, 2019, 79 (13)
[50] Radiosynthesis and evaluation of [18F]AFM, a selective PET tracer for the serotonin transporter.
Huang, Y
Bac, SA
Zhu, Z
Hwang, DR
Narendran, R
Talbot, PS
Hackett, E
Kegeles, LS
Laruelle, M
JOURNAL OF NUCLEAR MEDICINE, 2002, 43 (05) : 358P - 358P

← 1 2 3 4 5 →